1. Home
  2. SCLX vs INTG Comparison

SCLX vs INTG Comparison

Compare SCLX & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • INTG
  • Stock Information
  • Founded
  • SCLX 2011
  • INTG 1965
  • Country
  • SCLX United States
  • INTG United States
  • Employees
  • SCLX N/A
  • INTG N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • INTG Building operators
  • Sector
  • SCLX Health Care
  • INTG Real Estate
  • Exchange
  • SCLX Nasdaq
  • INTG Nasdaq
  • Market Cap
  • SCLX 35.7M
  • INTG 38.9M
  • IPO Year
  • SCLX N/A
  • INTG N/A
  • Fundamental
  • Price
  • SCLX $16.46
  • INTG $41.07
  • Analyst Decision
  • SCLX Buy
  • INTG
  • Analyst Count
  • SCLX 2
  • INTG 0
  • Target Price
  • SCLX $245.00
  • INTG N/A
  • AVG Volume (30 Days)
  • SCLX 255.7K
  • INTG 12.5K
  • Earning Date
  • SCLX 08-13-2025
  • INTG 11-12-2025
  • Dividend Yield
  • SCLX N/A
  • INTG N/A
  • EPS Growth
  • SCLX N/A
  • INTG N/A
  • EPS
  • SCLX N/A
  • INTG N/A
  • Revenue
  • SCLX $44,236,000.00
  • INTG $64,378,000.00
  • Revenue This Year
  • SCLX $89.26
  • INTG N/A
  • Revenue Next Year
  • SCLX $203.95
  • INTG N/A
  • P/E Ratio
  • SCLX N/A
  • INTG N/A
  • Revenue Growth
  • SCLX N/A
  • INTG 10.73
  • 52 Week Low
  • SCLX $3.60
  • INTG $9.57
  • 52 Week High
  • SCLX $39.90
  • INTG $42.50
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 47.62
  • INTG 84.78
  • Support Level
  • SCLX $13.08
  • INTG $27.11
  • Resistance Level
  • SCLX $14.74
  • INTG $32.00
  • Average True Range (ATR)
  • SCLX 1.51
  • INTG 5.59
  • MACD
  • SCLX -0.07
  • INTG 1.72
  • Stochastic Oscillator
  • SCLX 55.24
  • INTG 97.17

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

Share on Social Networks: